114.1 (v. br., 2-C), 49.4 slightly br (N(CH3)2); νmax: 2799, 2690,
2614, 2585, 1504, 1477, 1460, 1450, 1327, 1302, 1203, 1194,
1169, 1137, 985, 826, 806, 797, 773, 767, 717, 697, 543, 524,
395; HRMS: (LTQ Orbitrap XL, MeOH/H2O) found 200.1064,
C13H14NO+ requires 200.1070. The doubly labelled salt was pre-
pared in the same way from (Me215N(60%))-naphthalene-
8-(13C(99%)) carbaldehyde by the above method.
8.6 Hz, Ar-H1), 7.70 (1H, d, J = 8.2 Hz, Ar-H1), 7.60 (1H, t, J =
7.8 Hz, Ar-H1), 7.52 (1H, t, J = 8.0 Hz, Ar-H1), 7.31 (1H, d, J =
7.3 Hz, Ar-H1), 7.15 (1H, d, J = 6.9 Hz, Ar-H1), 7.11 (1H, s,
2′-H), 3.31 (6H, br s, 2 × NCH3), 2.78 (2H t, J = 6.4 Hz,) and
2.50 (2H t, J = 6.2 Hz) (3-,5-H2), 1.97 (2H, quin, J = 6.3 Hz,
4-H2); δC (CDCl3, 24 °C): 196.0 and 194.0 (2 × CvO), 146.9,
137.1, 131.7, 130.3, 128.6, 127.0, 126.6, 123. 0, 119.1, 111.8
(Ar-C10), 102.0 (1-C), 93.1 (2′-C), 52.2 br (N(CH3)2), 37.6 and
36.6 (3-,5-C), 21.2 (4-C); δH (CDCl3, −30 °C): 7.88 (1H, d, J =
8.1 Hz, Ar-H1), 7.73 (1H, d, J = 8.1 Hz, Ar-H1), 7.63 (1H, t, J =
7.6 Hz, Ar-H1), 7.55 (1H, t, J = 7.8 Hz, Ar-H1) 7.33 (1H, d, J =
7.3 Hz, Ar-H1), 7.18 (1H, d, J = 6.8 Hz, Ar-H1), 7.11 (1H, s,
2′-H), 3.57 (3H, s, NCH3), 3.14 (3H, s, NCH3), 2.53 (2H, m)
and 2.33 (2H, m, 3-,5-H2), 1.97 (2H, m, 4-H2); δC (CDCl3,
−30 °C): 196.2 and 194.4 (2 × CvO), 146.6, 136.9, 131.5,
130.4, 128.3, 127.0, 126.7, 123.0, 118.7, 111.8 (Ar-C10), 102.0
(1-C), 91.2 (2′-C), 55.2 and 49.6 (N(CH3)2), 37.6 and 36.6
(3-,5-C), 21.2 (4-C); νmax: 2930, 2870, 1606, 1587 w, 1521,
1500 sh, 1462, 1442, 1397, 1382, 1183, 1173, 1120, 1007, 980,
830, 777, 768, 736, 661, 624, 551, 529, 511, 434, 417; HRMS:
(LTQ Orbitrap XL, DCM/MeOH/NH4OAc) found: 294.1491
[M + H]+; C19H19NO2 + H+ requires 294.1489; found C, 77.63;
H, 6.48; N, 4.76%, C19H19NO2 requires C, 77.78; H, 6.53,
N: 4.78%.
Preparation of zwitterions 8–13
General procedure A: Aldehyde 1 (102 mg, 0.51 mmol), the
appropriate cyclic 1,3-dicarbonyl compound (0.52 mmol) and
ethylenediaminium diacetate (12 mg) were refluxed in dry
methanol (25 ml) for 6 h. Reduction of the solvent volume and
addition of ether, or evaporation of solvent and trituration with
ether, gave the product.
General procedure B: Aldehyde 1 (102 mg, 0.51 mmol), the
appropriate cyclic 1,3-dicarbonyl compound (0.52 mmol) and
ethylenediaminium diacetate (12 mg) in dry DMSO (2 ml) were
reacted at 100 °C for 10 min under microwave conditions
(200 W). After cooling to room temperature, water (5 ml) was
added and the mixture was extracted with ethyl acetate
(3 × 10 ml). The organic extract was washed with water
(3 × 15 ml) and brine (3 × 15 ml) and dried over MgSO4. Evapo-
ration of solvent and trituration with ether gave the product.
4,4-Dimethyl-1-(1′,1′-dimethyl-1′,2′-dihydrobenzo[cd]indol-1′-
ium-2′-yl)-2,6-dioxocyclohexan-1-ide, 10. Method B, yield 81%,
oily solid, δH (CDCl3, 24 °C): 7.86 (1H, d, J = 8.2 Hz, Ar-H1),
7.71 (1H, d, J = 8.2 Hz, Ar-H1), 7.61 (1H, t, J = 7.4 Hz, Ar-H1),
7.53 (1H, t, J = 7.8 Hz, Ar-H1), 7.32 (1H, d, J = 7.4 Hz, Ar-H1),
7.14 (1H, d, J = 7.2 Hz, Ar-H1), 7.13 (1H, s, 2′-H), 3.32 (6H, br
s, N-(CH3)2), 2.41 (s, 2H) and 2.19 (s, 2H) (3-,5-H2), 1.12 (6H,
s, 2 × 4-CH3); δC (CDCl3, 24 °C): 194.7 and 193.0 (2 × CvO),
146.8, 137.1, 131.7, 130.4, 127.7, 127.0, 126.6, 123.0, 119.2
and 111.8 (Ar-C10), 100.6 (2-C), 93.4 (2′-C), 52.0 (br s,
N-(CH3)2), 50.5 and 50.1 (3-,5-C), 31.3 (4-C), 28.8 (2 × 4-CH3);
νmax (film): 3028, 2943, 2885, 2016, 1604, 1589, 1525, 1467,
1439, 1405, 1384, 1279, 1260,1156; HRMS: (LTQ Orbitrap XL,
DCM/MeOH/NH4OAc) found: 322.1805 [M + H]+; C21H23NO2
+ H+ requires 322.1805.
1-(1′,1′-Dimethyl-1′,2′-dihydrobenzo[cd]indol-1′-ium-2′-yl)-
2,5-dioxocyclo-pentan-1-ide, 8. Method A, yield 81%, cream
powder, m.p. 135–137 °C; δH (CDCl3, 24 °C): 7.89 (1H, d, J =
8.3 Hz, Ar-H1), 7.77 (1H, d, J = 8.2 Hz, Ar-H1), 7.64 (1H, t, J =
7.6 Hz, Ar-H1), 7.52 (1H, t, J = 7.8 Hz, Ar-H1), 7.37 (1H, d,
J = 7.4 Hz, Ar-H1), 7.15 (1H, d, J = 6.8 Hz, Ar-H1), 6.53 (1H, s,
2′-H), 3.31 (6H, s, 2 × NCH3), 2.48 (2H, br s, 3-,4-H2); δC
(CDCl3, 24 °C): 203.0 br (2 × CvO), 146.3, 133.7, 131.8,
130.5, 128.7, 127.3, 126.9, 124.2, 121.2, 112.3 (Ar-C10), 99.3
(1-C), 88.9 (2′-C), 52.2 (N(CH3)2), 33.4 (3-,4-C); δH (CDCl3,
−48 °C): 7.93 (1H, d, J = 8.3 Hz, Ar-H1), 7.81 (1H, d, J = 8.2
Hz, Ar-H1), 7.67 (1H, t, J = 7.6 Hz, Ar-H1), 7.60 (1H, t, J = 7.8
Hz, Ar-H1), 7.42 (1H, d, J = 7.3 Hz, Ar-H1), 7.29 (1H, d, J =
6.9 Hz, Ar-H1), 6.49 (1H, s, 2′-H), 3.57 (3H, s, NCH3), 3.13
(3H, s, NCH3), 2.49 (4H, br m, 3-,4-H2); δC (CDCl3, −48 °C):
204.6 and 203.0 (2 × CvO), 145.8, 133.3, 131.5, 130.4, 128.3,
127.3, 126.9, 124. 2, 120.2, 112.3 (Ar-C10), 99.4 (1-C), 86.9 (2′-C),
52.6 and 51.8 (2 × N-CH3), 33.4 and 33.1 (3-,4-C); δC
(DMSO-d6, 65 °C): 199.7 (2 × CvO), 146.9, 135.2, 130.8,
129.4, 128.2, 127.3, 126.0, 123. 2, 119.7, 113.8 (Ar-C10), 98.2
(1-C), 87.8 (2′-C), 51.5 (2 × N-CH3), 32.7 (3-,4-C); at 24 °C,
the spectrum is very similar, apart from the carbonyl C resonance
appears as a broad signal at 200.1 ppm; νmax: 3396, 3173, 3018,
2908, 1547, 1498, 1446, 1435, 1369, 1347, 1283, 1263, 1234
1024, 994, 906, 833, 826, 807, 785, 778, 749, 703, 640, 632,
610, 530, 478, 411; HRMS: (LTQ Orbitrap XL, DCM/MeOH/
NH4OAc) found 280.1330, C18H17NO2 + H+ requires 280.1332;
found: C 77.58, H 5.94, N 4.86%, C18H17NO2 requires C 77.40,
H 6.13, N 5.01%.
1-(1′,1′-Dimethyl-1′,2′-dihydrobenzo[cd]indol-1′-ium-2′-yl)-4-
phenyl-2,6-dioxocyclohexan-1-ide, 11. Method B, 38%, cream
solid, m.p. 142–144 °C; δH (CDCl3, 24 °C): 7.90 (1H, d,
J 8.2 Hz, Ar-H1), 7.76 (1H, d, J 8.3 Hz, Ar-H1), 7.66 (1H, t, J =
7.6 Hz, Ar-H1), 7.56 (1H, t, J = 7.8 Hz, Ar-H1), 7.33 (5H, m, o-,
m-phenyl-H3 + Ar-H2), 7.22 (2H, m, para-Ph-H1 + Ar-H1), 7.16
(1H, s, 2′-H), 3.47 (1H, br s, 4-H), 3.31 (6H, br s, N(CH3)2),
2.83 (2H, m) and 2.60 (2H, m) (3-,5-H2); δC (CDCl3, 24 °C):
194.7 and 192.9 (2 × CvO), 146.9 (Ar-C1), 144.4 (ipso-Ph-C1),
136.9, 131.8, 130.5, 128.7 (Ar-C4), 128.5 (Ph-C2), 127.1
(Ar-C1), 126.8 (Ph-C2), 126.7 (Ar-C1), 126.3 (para-Ph-C1),
123.2, 119.2, 111.8 (Ar-C3), 101.5 (br s, 1-C), 92.6 (2′-C), 52.0
(br s, 2 × N-CH3), 44.8 and 43.9 (3-,5-C), 38.9 (4-C); δH
(CD2Cl2, −40 °C): 7.94 (1H, d, J = 8.4 Hz, Ar-H1), 7.79 (1H, t,
J = 7.4 Hz, Ar-H1), 7.65 (m), 7.44 (m), 7.33 (m), 7.22 (m) and
7.13(m) (Ar-H9), 7.03 (7.09) (1H, s, 2′-H), 3.57 (3.54) (3H, s,
N-CH3), and 3.13 (3.17) (3H, s, N-CH3), 2.71 (2H, m, 3-,5-Hα),
2.47 (2H, m, 3-,5-Hα); δC (CD2Cl2, −40 °C): 192.7 (192.2) and
1-(1′,1′-Dimethyl-1′,2′-dihydrobenzo[cd]indol-1′-ium-2′-yl)-
2,6-dioxocyclo-hexan-1-ide, 9. Method A, yield 46%, cream
powder, m.p. 154–155 °C; δH (CDCl3, 24 °C): 7.85 (1H, d, J =
This journal is © The Royal Society of Chemistry 2012
Org. Biomol. Chem., 2012, 10, 7763–7779 | 7775